Publicação na área de Mastologia
On line first do New England Journal of Medicine, edição on line de 25 de setembro de 2011 estudo randomizado do Reino Unido. | September 25, 2011
The following article was published at NEJM.org to coincide with an embargo lifting at the 2011 European Multidisciplinary Cancer Congress.
R.E. Coleman and Others
These findings do not support the routine use of zoledronic acid in the adjuvant management of breast cancer. (Funded by Novartis Pharmaceuticals and the National Cancer Research Network; AZURE Current Controlled Trials number, ISRCTN79831382.)
0 visualização0 comentário